# Braemar Hotels & Resorts Inc.: overview BHR · NYSE · CIK 1574085 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bhr.md) · [Financials](/companies/bhr/financials.md) · [Filings](/companies/bhr/filings.md) · [Insiders](/companies/bhr/insiders.md) Latest reported revenue: [$171.0m](/filings/0001574085-26-000130.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001574085-26-000130). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [148](/filings/0001574085-25-000130.md) | [173 d](/filings/0001574085-26-000038.md) | [216](/filings/0001574085-26-000079.md) | [179](/filings/0001574085-26-000130.md) | [144](/filings/0001574085-25-000130.md) | [166 d](/filings/0001574085-26-000038.md) | [209](/filings/0001574085-26-000079.md) | [171](/filings/0001574085-26-000130.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [47.4%](/filings/0001574085-25-000130.md) | [2.2% d](/filings/0001574085-26-000038.md) | [17.0%](/filings/0001574085-26-000079.md) | [10.0%](/filings/0001574085-26-000130.md) | [20.8%](/filings/0001574085-25-000130.md) | [(7.3%) d](/filings/0001574085-26-000038.md) | [19.0%](/filings/0001574085-26-000079.md) | [17.9%](/filings/0001574085-26-000130.md) | | Net margin | % | [8.5%](/filings/0001574085-25-000130.md) | [(10.8%) d](/filings/0001574085-26-000038.md) | [5.1%](/filings/0001574085-26-000079.md) | [(3.1%)](/filings/0001574085-26-000130.md) | [4.0%](/filings/0001574085-25-000130.md) | [(20.3%) d](/filings/0001574085-26-000038.md) | [8.5%](/filings/0001574085-26-000079.md) | [4.1%](/filings/0001574085-26-000130.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001574085-25-000130.md) | not reported | [(0.04)](/filings/0001574085-26-000079.md) | [(0.24)](/filings/0001574085-26-000130.md) | [(0.12)](/filings/0001574085-25-000130.md) | not reported | [0.07](/filings/0001574085-26-000079.md) | [(0.01)](/filings/0001574085-26-000130.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [428](/filings/0001574085-24-000033.md) | [670](/filings/0001574085-25-000024.md) | [739](/filings/0001574085-26-000038.md) | [728](/filings/0001574085-26-000038.md) | [704](/filings/0001574085-26-000038.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [0.3%](/filings/0001574085-24-000033.md) | [10.2%](/filings/0001574085-25-000024.md) | [8.3%](/filings/0001574085-26-000038.md) | [17.7%](/filings/0001574085-26-000038.md) | [10.3%](/filings/0001574085-26-000038.md) | | Net margin | % | [(6.2%)](/filings/0001574085-24-000033.md) | [2.7%](/filings/0001574085-25-000024.md) | [(3.7%)](/filings/0001574085-26-000038.md) | [(0.2%)](/filings/0001574085-26-000038.md) | [(3.2%)](/filings/0001574085-26-000038.md) | | Diluted EPS | $ per share | [(0.76)](/filings/0001574085-24-000033.md) | [(0.15)](/filings/0001574085-25-000024.md) | [(1.13)](/filings/0001574085-26-000038.md) | [(0.77)](/filings/0001574085-26-000038.md) | [(1.07)](/filings/0001574085-26-000038.md) | | Free cash flow | $m | [46.3](/filings/0001574085-24-000033.md) | [(245)](/filings/0001574085-25-000024.md) | [84.7](/filings/0001574085-26-000038.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bhr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.7m | 8,653,340 | | Added +302,540 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.9m | 2,737,146 | | Reduced −17,370 | | [ZAZOVE ASSOCIATES LLC](/funds/1009012.md) | 2026-06-30 | $4.8m | 2,217,055 | | Not compared | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.3m | 1,510,399 | | Added +104,001 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.8m | 1,312,676 | | Reduced −35,652 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $2.5m | 1,142,971 | | Added +92,709 | | [LANDMARK INVESTMENT PARTNERS, L.P.](/funds/2023551.md) | 2026-06-30 | $2.0m | 988,883 | | Reduced −150,915 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $1.9m | 857,674 | | Added +651,485 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.5m | 706,500 | | Reduced −25,400 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $1.3m | 592,777 | | Added +358,896 | ## Recent filings [All 1,452 filings](/companies/bhr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 17:05 ET | [SCHEDULE 13D/A](/filings/0001398344-26-019197.md) | Ownership report, active investor, amended | 0001398344-26-019197 | | 2026-10-26 | 06:30 ET | [8-K](/filings/0001104659-26-118592.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118592 | | 2026-10-16 | 16:43 ET | [8-K](/filings/0001574085-26-000157.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001574085-26-000157 | | 2026-10-13 | 06:15 ET | [8-K](/filings/0001574085-26-000153.md) | 7.01 Regulation FD disclosure | 0001574085-26-000153 | | 2026-10-08 | 16:51 ET | [SCHEDULE 13D/A](/filings/0001398344-26-018042.md) | Ownership report, active investor, amended | 0001398344-26-018042 | | 2026-10-08 | 16:08 ET | [8-K](/filings/0001574085-26-000151.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001574085-26-000151 | | 2026-10-08 | 16:01 ET | [8-K](/filings/0001104659-26-114691.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-114691 | | 2026-09-29 | 16:04 ET | [8-K](/filings/0001574085-26-000146.md) | 1.01 Entry into a material agreement | 0001574085-26-000146 | | 2026-09-23 | 16:21 ET | [8-K](/filings/0001574085-26-000141.md) | 8.01 Other events | 0001574085-26-000141 | | 2026-09-15 | 18:44 ET | [SCHEDULE 13D/A](/filings/0001398344-26-017023.md) | Ownership report, active investor, amended | 0001398344-26-017023 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001574085-26-000038.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e36721cd-4aea-4ddb-ab0e-1bf95ec9e1c9) ## About the filer - CIK: 1574085 - Tickers: BHR, BHR-PB, BHR-PD - Exchange: NYSE - SIC code: 6798 Real Estate Investment Trusts - State of incorporation: MD - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 17:15 ET. No prices; not investment advice.